Streetbeat News

Stock Prices

REGN

SNY

VRNA

The FDA has approved Verona Pharma's (NASDAQ:VRNA) Ohtuvayre (ensifentrine) for the maintenance treatment of COPD, marking the first inhaled product with a novel mechanism of action for COPD in over 20 years. The drug is expected to generate $3.6 billion in peak sales and will be available in Q3 2024. The FDA also extended the review date for Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals' (NASDAQ:REGN) Dupixent for COPD treatment to September 27, 2024.

Portfolio Pulse from Vandana Singh

June 27, 2024 | 1:49 pm

BTCUSD

Crypto journalist Laura Shin predicts a potential rebound for Bitcoin (BTC) in July, following a typical June slump. Historical data shows Bitcoin often recovers strongly in July after a negative June. Factors like lack of new capital, selling pressure from the German government, and impending Mt. Gox disbursements are contributing to the current decline. However, experts suggest that the Mt. Gox repayments may not trigger a significant sell-off. JPMorgan analysts forecast temporary market pressure in July but expect a recovery in August.

Portfolio Pulse from Khyathi Dalal

June 27, 2024 | 1:47 pm

AVGO

Investors with significant capital have shown a bullish stance on Broadcom (NASDAQ:AVGO), as evidenced by 27 uncommon options trades spotted by Benzinga's options scanner. The sentiment is split with 44% bullish and 33% bearish. Analysts have set an average price target of $1809.0, with ratings predominantly being 'Buy'.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 1:46 pm

META

High-rolling investors have shown significant interest in Meta Platforms (NASDAQ:META) options, with a notable split in sentiment: 47% bullish and 33% bearish. The options activity suggests a targeted price range of $495 to $530. Analysts have mixed ratings, with target prices ranging from $450 to $550.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 1:46 pm

GRDI

Trading halt status for GRDI was updated at 9:45:00 AM ET. The halt was due to news and resumption times.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 1:45 pm

ELAN

Elanco Animal Health shares have resumed trading after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 1:44 pm

BAC

JPM

USB

WFC

The Federal Reserve's 2024 Stress Test results revealed that major American banks, including Wells Fargo, Bank of America, Morgan Stanley, and U.S. Bancorp, faced higher-than-expected potential losses. The market is likely to view these results as disappointing, with significant increases in Stress Test Capital Buffers (SCBs) for several banks.

Portfolio Pulse from Piero Cingari

June 27, 2024 | 1:43 pm

ELAN

Elanco Animal Health shares were halted on a circuit breaker due to a significant drop, with the stock now down 17.9%.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 1:39 pm

AMD

NVDA

QQQ

SPY

Advanced Micro Devices, Inc (NASDAQ:AMD) shares were trading lower in the premarket session in sympathy with Micron Technology Inc (NASDAQ:MU) after Micron's third-quarter financial results. However, AMD recovered in regular trading. AMD is set to introduce a new AI-driven technology to enhance gaming by reducing download times, to be showcased in July. AMD is also rebranding its laptop gaming CPUs under the AMD AI moniker, similar to Nvidia Corp (NASDAQ:NVDA). AMD stock has gained 43% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

June 27, 2024 | 1:38 pm

AAPL

AMD

NVDA

QCOM

TSM

Taiwan Semiconductor Manufacturing Co (NYSE:TSM) has received approval to construct its third 2nm fab in Kaohsiung, expanding its regional footprint. This move aims to meet the growing demand for AI chips, particularly from Nvidia (NASDAQ:NVDA). TSMC's key customers, including Apple (NASDAQ:AAPL), Qualcomm (NASDAQ:QCOM), and Advanced Micro Devices (NASDAQ:AMD), have nearly booked its 3nm process to capacity through 2026. Analysts predict a rise in chip manufacturing prices and potential revenue guidance increases for TSMC.

Portfolio Pulse from Anusuya Lahiri

June 27, 2024 | 1:34 pm